Arca
Skip to content

INNOVERSE Navigation Instruments

Orthopedic Stereotaxic Instrument. 510(k) K241082, from Innosys Co., Ltd. (Uijeongbu-Si, KR). Product code OLO, class 2.

As of Nov 17, 2026, K241082 is an FDA 510(k) held by Innosys Co., Ltd., substantially equivalent on Jun 14, 2024 after 56 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jun 14, 2024
  • Review time: 56 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

INNOVERSE Navigation Instruments are intended to be used during the preparation and placement of INNOVERSE Spinal System implants during spinal surgery to assist the surgeon in precisely locating anatomical structures in spinal procedures.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other OLO Clearances

The newest 510(k)s for the same product code; their median review was 91 days; see every OLO device

Record

Type
Traditional
Received
Apr 19, 2024
Review panel
Neurology
Regulation
21 CFR 882.4560

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.